Insider Trading April 28, 2026 04:04 PM

Nasdaq Executive Executes Stock Sale Amid Recent Earnings Outperformance

Michelle Lynn Daly disposes of 1,323 shares as the exchange continues to navigate strong financial momentum and shifting market interest.

By Marcus Reed NDAQ
Nasdaq Executive Executes Stock Sale Amid Recent Earnings Outperformance
NDAQ

In a recent regulatory filing, Michelle Lynn Daly, who serves as the Senior Vice President, Controller, and Principal Accounting Officer at NASDAQ, Inc. (NDAQ), disclosed a sale of company stock. The transactions, which took place on April 24, 2026, involved the sale of 1,323 shares of common stock for a total value of $117,512. The execution of these trades occurred at price points ranging from $88.82 to $88.85 per share.This insider activity was formally reported via a Form 4 filing with the Securities and Exchange Commission on April 28, 2026. Despite this divestment, Ms. Daly maintains a significant direct holding in the company, totaling 10,089 shares of NASDAQ common stock. This remaining position is composed of several different categories: 6,787 unvested units of restricted stock, 1,764 shares underlying Performance Share Units (PSUs) which are also unvested, and 1,538 shares acquired through the company's Employee Stock Purchase Plan.

Key Points

  • NASDAQ reported Q1 2026 earnings of $0.96 EPS, beating the $0.93 estimate.
  • Revenue for the quarter reached $2.14 billion, significantly higher than the projected $1.37 billion.
  • Raymond James raised its price target to $111 while maintaining an Outperform rating.

Executive Transaction Details

On April 24, 2026, Michelle Lynn Daly, acting in her capacity as Senior Vice President, Controller, and Principal Accounting Officer for NASDAQ, Inc. (NDAQ), completed the sale of 1,323 shares of common stock. The total proceeds from these transactions amounted to $117,512, with the shares being sold within a narrow price range between $88.82 and $88.85.

Following this transaction, Ms. Daly's direct ownership in NASDAQ stands at 10,089 shares. A breakdown of her current holdings includes:

  • 6,787 shares or units of restricted stock (none currently vested)
  • 1,764 shares of common stock tied to PSUs (none currently vested)
  • 1,538 shares purchased via the Issuer’s Employee Stock Purchase Plan

Financial Context and Market Performance

The insider sale occurs against a backdrop of recent positive financial reporting from NASDAQ, Inc. The company reported robust first-quarter 2026 earnings that exceeded market consensus. Specifically, NASDAQ posted an earnings per share (EPS) of $0.96, surpassing the anticipated $0.93. Revenue figures also outperformed expectations, with the company reporting $2.14 billion in revenue compared to a projected $1.37 billion.

In response to these financial results, Raymond James adjusted its outlook for the stock, raising its price target from $110 to $111 while maintaining an Outperform rating. Analysts cited the company's momentum within its index franchise and financial technology businesses as key drivers for this stance. However, it is noted that based on Fair Value assessments, NASDAQ currently appears to be overvalued.

Key Market Indicators

The broader market activity surrounding Nasdaq securities also shows notable shifts. As of the April 15 settlement date, short interest across all Nasdaq securities reached 20.5 billion shares, representing an increase from the previous period's level of 20.4 billion shares. Additionally, there was a slight increase in short interest specifically within Nasdaq Global Market securities.

Key Points:

  • Earnings Strength: NASDAQ demonstrated significant top and bottom-line outperformance in Q1 2026, with revenue exceeding projections by $770 million.
  • Analyst Sentiment: Despite valuation concerns, major analysts like Raymond James remain bullish on the company's fintech and index segments.
  • Market Participation: Rising short interest across Nasdaq securities suggests active hedging or speculative positioning in the market.

Risks and Uncertainties:

  • Valuation Discrepancies: Current assessments suggest the stock may be trading above its Fair Value, presenting a potential risk for investors.
  • Short Interest Trends: The rise in short interest across all Nasdaq securities and specifically within Global Market securities indicates shifting investor sentiment or increased hedging activity.

Risks

  • Fair Value assessments suggest the company is currently overvalued.
  • Short interest in Nasdaq securities rose to 20.5 billion shares as of April 15.
  • Short interest in Nasdaq Global Market securities has seen a slight increase.

More from Insider Trading

United Therapeutics CFO Executes $5.69 Million Stock Sale via Pre-Scheduled Trading Plan Apr 28, 2026 Belite Bio Chief Scientific Officer Executes Planned Share Sale Amid Regulatory Milestones Apr 28, 2026 Remitly Global Executive Executes Planned Stock Sale Amid Strong Financial Performance Apr 28, 2026 Valmont Industries Director Mogens C. Bay Executes $8.6 Million Share Sale Apr 28, 2026 Applied Digital Director Executes Stock Sale Amid Significant Revenue Growth and Major Lease Agreement Apr 28, 2026